Abstract
Hyperseborrhea has been considered as a major etiopathogenetic factor of acne. However, changes in sebaceous gland activity not only correlate with seborrhea but also with alterations in sebum fatty acid composition. Current findings indicate that sebum lipid fractions with proinflammatory properties and inflammatory tissue cascades are associated in the process of the development of acne lesions. The oxidant/antioxidant ratio of the skin surface lipids and alterations of lipid composition are the main players in the induction of acne inflammation. Nutrition may influence the development of seborrhea, the fractions of sebum lipids, and acne. Acne is an inflammatory disease probably triggered, among others, by proinflammatory sebum lipid fractions.
An article with similar content has been published in: Zouboulis CC, Jourdan E, Picardo M. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol. 2014;28:527–32.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
FormalPara Core Messages-
Hyperseborrhea has been considered as a major etiopathogenetic factor of acne.
-
Changes in sebaceous gland activity not only correlate with seborrhea but also with alterations in sebum fatty acid composition.
-
Sebum lipid fractions with proinflammatory properties are associated in the process of the development of acne lesions.
-
The oxidant/antioxidant ratio of the skin surface lipids and alterations of lipid composition are the main players in the induction of acne inflammation.
-
Nutrition may influence the development of seborrhea, the fractions of sebum lipids, and acne.
Introduction: Inflammation in Acne
Induction of inflammatory signalling in the pilosebaceous unit is a major component in the process of the initiation of acne lesions (Zouboulis 2001, 2004a; Zouboulis et al. 2005). Among the 211 upregulated and the 18 downregulated genes in lesional skin of acne patients—compared to normal human skin—a significant proportion is involved in pathways that regulate inflammation (Trivedi et al. 2006a). Scarce inflammatory infiltrates around the ductus seboglandularis, and later on perifollicular infiltration and enhanced cytokine expression at the mRNA and protein levels are closely associated with comedone formation (Jeremy et al. 2003); comedones do not develop in a later stage leading to “inflammatory comedones,” as previously reported (Chiba et al. 2000). NF-κB, a transcription factor critical for upregulation of several proinflammatory cytokine genes, has been shown to be activated in acne lesions (Kang et al. 2005). Interestingly, interleukin (IL)-1α is strongly expressed in comedones (Chiba et al. 2000; Anttila 1992; Ingham et al. 1992). It induces hyperproliferation, assessed by the enhanced expression of the hyperproliferative markers keratin (K) 6 and K16 (Hughes et al. 1996) and disturbs terminal differentiation of infundibular keratinocytes, which is related to increased filaggrin expression (Kurokawa et al. 1988), leading to hyperkeratinization in the follicular infundibulum detected in vivo and ex vivo (Guy et al. 1996). IL-1α activates basal keratinocytes by autocrine production inducing K16 expression in suprabasal cells in the active state.
Sebaceous Glands and Innate Immunity
Follicular keratinocytes and sebocytes, the major components of the pilosebaceous unit, may act as symbiotically or immune responding cells capable of microbia recognition and abnormal lipid presentation (Koreck et al. 2003). Innate immunity molecules, such as toll-like receptor (TLR)2, TLR4, CD1d, and CD14, are expressed in human keratinocytes (Song et al. 2002) and SZ95 sebocytes (Koreck et al. 2003; Oeff et al. 2006). Acting that way, keratinocytes and sebocytes may be activated by Propionibacterium acnes (P. acnes) and recognize altered lipid content in sebum, followed by the production of proinflammatory cytokines. In addition, antimicrobial peptides, such as defensin-1, defensin-2, and cathelicidin, are expressed and are active in the sebaceous gland (Chronnell et al. 2001; Nagy et al. 2006; Nakatsuji et al. 2010; Chen et al. 2011). Human β-defensin-2 is expressed upon exposure to lipopolysaccharides and P. acnes (Nagy et al. 2006) and upregulated by sebum free fatty acids (Nakatsuji et al. 2010).
Sebum and Acne
The most obvious function of the sebaceous gland is to excrete sebum (Zouboulis 2004a). Sebum is a mixture of relatively nonpolar lipids, most of which are synthesized de novo by the sebaceous glands (Nikkari 1974). The composition of sebum is remarkably species- and age-specific (Nikkari 1974; Ramasastry et al. 1970; Picardo et al. 2009; Pappas 2009a). Human sebaceous glands secrete a lipid mixture containing squalene and wax esters, as well as cholesterol esters, triglycerides, and possibly some free cholesterol and fatty acids.
For a long time, hyperseborrhea has been considered as a major etiopathogenetic factor for acne. However, emerging data on alterations of sebum composition in acne patients (Picardo et al. 2009; Makrantonaki et al. 2011; Pappas et al. 2009) indicate that sebum composition may be more important for the development of acne lesions than the secreted amount. Indeed, bacterial hydrolases convert some of the triglycerides to free fatty acids on the skin surface (Nicolaides and Wells 1957). On the other hand, there is also evidence that sebaceous glands can also synthesize considerable amounts of free fatty acids (Zouboulis 2001).
Indeed, the oxidant/antioxidant ratio of the skin surface lipids (Stewart et al. 1986) has been taken into consideration in the etiopathogenesis of acne and other skin diseases. Oxygen and micro-organisms transform “native” sebum, with lysis of triglycerides into fatty acids being their most pronounced activity (Patel and Noble 1992; Saint-Léger 2003). The quantities of lipid peroxide, IL-1α, and NF-κB were found significantly higher in the content of comedones than those in the stratum corneum (Tochio et al. 2009). Certain components of this complex mixture of molecules present in the sebum are clearly cytotoxic or irritant, provoking reactive follicular hyperkeratosis and comedone formation—the first step to acne. Particular attention has been focused on peroxidation of squalene, a sebaceous gland-specific lipid, e.g., by ultraviolet radiation, which led to comedogenesis on the rabbit ear skin (Chiba et al. 2000). Squalene peroxide has been shown to induce an inflammatory response in HaCaT keratinocytes through lipoxygenase activation and increase in the proinflammatory cytokine IL-6 production (Ottaviani et al. 2006). Inflammation of acne-involved sebaceous glands is also associated with lipoxygenase activation and intracellular IL-6 increase (Alestas et al. 2006). Therefore, lipoxygenase activity products may contribute to an implementation of the inflammatory reaction with a concomitant anti-inflammatory feedback response of noninvolved cells of the pilosebaceous unit, as demonstrated by the concomitant increase of concomitant peroxisome proliferator-activated receptor (PPAR)α mRNA and protein levels. The clinical relevance of these findings were corroborated by the antiacne activity of zileuton, a 5-lipoxygenase (5-LOX) inhibitor (Zouboulis 2009; Zouboulis et al. 2010).
Stearoyl-CoA desaturase (SCD) and fatty acid desaturase (FADS)-2 are enzymes responsible for the biosynthesis of monounsaturated fatty acids in human sebocytes. In a feedback mode, their expression is downregulated by their products and upregulated by the unspecific Gram + bacterial antigen and TLR-2 ligand macrophage-activating lipopeptide-2 MALP-2 (Georgel et al. 2005; Zouboulis et al. 2011). Interestingly, while P. acnes is unable to induce IL-1α expression in the pilosebaceous unit (Ingham et al. 1998; Seltmann et al. 2000), oleate (C18:1)—through keratinocyte toxicity—causes increased IL-1α mRNA levels. Therefore, alterations of saturated and unsaturated fatty acid composition in sebum have currently been taken into consideration as initiators of follicular inflammation and regulators of innate symbiotic and immunity response (Makrantonaki et al. 2011; Ottaviani et al. 2006). Among the sebum lipids, the ones produced by the sebaceous glands are of great importance for the development of acne. Lower essential fatty acid levels were found in wax esters in twins with acne than in twins without acne (Stewart 1992). Several free fatty acids were detected to express proinflammatory and anti-inflammatory properties (Nakatsuji et al. 2010; Alestas et al. 2006; Wróbel et al. 2003; Makrantonaki and Zouboulis 2007). For example, high levels of linoleate (C18:2), an essential ω6-fatty acid (Stewart et al. 1986), may protect from the development of comedonal acne (Nicolaides et al. 1972) and its topical application reduces microcomedones and inhibits steroid 5α-reductase activity (Letawe et al. 1998; Namazi 2004). On the other hand, low linoleate levels have been observed in skin surface lipids of acne patients (Downing et al. 1986). However, neither all ω6-fatty acids are comedogenic, not all ω9-fatty acids inhibit comedogenesis (Fig. 23.1). For example, oleate alters the calcium dynamics in epidermal keratinocytes and induces abnormal follicular keratinization leading to comedogenesis in rabbit skin (Choi et al. 1997; Katsuta et al. 2005) but to minor irritation in human skin (Boelsma et al. 1996). SZ95 sebocytes in vitro were currently shown to produce the same amount of lipids after incubation with linoleate and palmitate (16:0). However, their effects on sebocyte inflammatory signaling were strikingly different (Seltmann et al. 2013).
On the other hand, fatty acids exhibit strong antimicrobial activity. The sebaceous ω9-fatty acids sapienate (C16:1δ6), palmitate (C16:0), and oleate (C18:1) are very effective against Staphylococcus aureus (Chen et al. 2011; Georgel et al. 2005; Wille and Kydonieus 2003; Drake et al. 2008). Moreover, dysfunction of the upstream lipidogenic enzymes SCD and FADS-2 is associated with skin infection and inflammation (Georgel et al. 2005; Seltmann et al. 2000). Lipids at the skin surface, mostly secreted from the sebaceous glands (90 %) and transported through the follicular canal, are part of the symbiotic and innate immunity of the skin and contribute to the antimicrobial skin barrier.
PPAR and Acne
Certain lipid mediators, which are able to interfere with sebocyte differentiation and lipogenesis, have been shown to activate and/or be ligands of PPAR (Makrantonaki et al. 2011; Ottaviani et al. 2006; Alestas et al. 2006; Chen et al. 2003; Zhang et al. 2006). Importantly, lipid peroxidation products are also capable of inducing PPAR activation and production of proinflammatory cytokines. In particular, PPARα seems to be related to β-oxidation of fatty acids and lipid catabolism, whereas PPARγ activation has been linked to lipogenesis (Ferré 2004). Eicosanoid metabolites originated from the arachidonic acid cascade, namely leukotriene B4 and 15-HETE, have been shown to be ligands of PPARα and PPARγ, respectively (reviewed in Zouboulis et al. 2005; Alestas et al. 2006). Interestingly, the enzymes involved in their formation, including 5-LOX, have been implicated in inflammatory skin diseases characterized by keratinocyte hyperproliferation (Ottaviani et al. 2006) and have been found to be expressed at higher extent in acne-involved skin in comparison to the skin of healthy subjects (Alestas et al. 2006). Activation of 5-LOX results, among other effects, in induced IL-6 and IL-8 expression in human sebocytes, whereas enhanced expression of IL-6 and IL-8 has also been found in acne-affected skin (Alestas et al. 2006). Systemic treatment of acne patients with the 5-LOX inhibitor Zileuton reduces the inflammatory lesion count and the synthesis of sebum lipids, in particular, of those with proinflammatory potential (Zouboulis 2009) through an inflammation-preventive mechanism (Zouboulis et al. 2010). 5-LOX inhibitors may also downregulate the inflammatory activity of lymphocytes and macrophages resulting in cumulative beneficial effects (Jeremy et al. 2003).
Prostaglandins are further proinflammatory mediators thought to be involved in acne lesion development (Zhang et al. 2006). Mice with increased cyclooxygenase-2 (COX-2) expression and prostaglandins E2 levels showed sebaceous gland hyperplasia and enhanced sebum production (Neufang et al. 2001) suggesting an important role for COX-2 signaling pathway in sebocyte biology. Expression and activation of COX-2 has been shown in in vitro models to be PPARγ mediated. General oxidative stressors, including lipid oxidizing agents, activate PPARγ and induce lipogenesis in sebocytes (Trivedi et al. 2006a, b; Zhang et al. 2006; Ottaviani et al. 2010). All these findings allow the hypothesis that sebocyte proliferation and/or lipogenesis as well as inflammatory reaction, may be regulated by PPARγ-mediated pathways.
Neuropeptides
Corticotropin-releasing hormone (CRH), the most proximal element of the hypophysis-pituitary-adrenal axis, acts as a central coordinator for neuroendocrine and behavioral responses to stress. CRH, CRH-binding protein, CRH-receptor 1, and CRH-receptor 2 are expressed in SZ95 sebocytes at mRNA and protein level, whereas CRH-receptor 1 is the predominant type (Zouboulis et al. 2002). In addition, CRH significantly upregulates mRNA levels of 3β-hydroxysteroid dehydrogenase/Δ5−4 isomerase and induces sebaceous lipogenesis and IL-6 and IL-8 synthesis (Zouboulis et al. 2002; Krause et al. 2007). In acne-involved skin, the complete CRH system is abundant especially in the sebaceous glands, possibly activating lipid pathways, which affect immune and inflammatory processes leading to the development and stress-induced exacerbation of acne (Ganceviciene et al. 2009).
Diet
Evidence suggests that diet may influence acne (Rasmussen 1997; Pappas 2009b; Liakou et al. 2013; Smith et al. 2007), whereas it is also an important source of substrate for the synthesis of sebaceous lipids (Rasmussen 1997). This notion is supported also by the observation that sebum contains essential fatty acids, such as linoleate and oleate. On the other hand, extreme caloric restriction dramatically decreases the sebum excretion rate and these changes can be reversed when a normal diet is resumed (Pochi et al. 1970; Downing et al. 1972). Other studies have demonstrated that increased consumption of dietary fat or carbohydrate increases sebum production and modifications to the type of carbohydrate can also alter sebum composition (Macdonald 1964). Typical western diet, comprised of milk and hyperglycaemic foods, may have potentiating effects on serum insulin and insulin-like growth factor-1 levels, thereby promoting the development of acne (Melnik and Schmitz 2009). In contrast, a low-glycemic-load diet for 12 weeks in acne patients reduced parallelly the acne lesion count and increased the C16:0/C16:1 fatty acid ratio (Smith et al. 2007, 2008) suggesting an increased enzymatic desaturation of fatty acids in the sebaceous glands of patients with acne (Fig. 23.2).
The nutritional cell status is primarily sensed by the forkhead box transcription factor O1 (FoxO1) and the serine/threonine kinase mammalian target of rapamycin complex 1 (mTORC1) (Wang et al. 2011). FoxO1 attenuates androgen signaling, interacts with regulatory proteins important for sebaceous lipogenesis, regulates the activity of innate and adaptive immunity, antagonizes oxidative stress, and most importantly functions as a rheostat of mTORC1, the master regulator of cell growth, proliferation, and metabolic homoeostasis. Thus, FoxO1 links nutrient availability to mTORC1-driven processes in the skin: increased protein and lipid synthesis, cell proliferation, cell differentiation including hyperproliferation of acroinfundibular keratinocytes, sebaceous gland hyperplasia, and increased sebaceous lipogenesis (Melnik and Zouboulis 2013). Deeper insights into the molecular interplay of FoxO1/mTORC1-mediated nutrient signaling are thus of critical importance to understand the impact of western diet on the promotion of epidemic acne.
Conclusions
Increased sebum excretion, alteration of lipid composition and the oxidant/antioxidant ratio of the skin surface lipids are major concurrent events associated with the development of acne (Zouboulis 2004a; Table 23.1). Current evidence indicates that sebum composition (lipid quality), and not quantity, plays a central role in the development of acne. This concept is supported by the mode of action of new antiacne compounds, such as the 5-LOX inhibitor Zileuton, which reduces acne lesions by inhibiting proinflammatory lipids (Zouboulis 2009; Zouboulis et al. 2010), and the current evidence of the effect of diet on acne (Melnik and Schmitz 2009). Moreover, old data on in vivo and in vitro modulation of sebaceous lipid composition by isotretinoin, the most potent antiacne drug, can be approached from this new perspective (Stewart et al. 1984; Strauss et al. 1987; Melnik et al. 1988; Zouboulis et al. 1991).
Abbreviations
- 5-LOX:
-
5-lipoxygenase
- COX-2:
-
Cyclooxygenase-2
- CRH:
-
Corticotropin-releasing hormone
- FADS:
-
Fatty acid desaturase
- FoxO1:
-
Forkhead box transcription factor O1
- IL:
-
Interleukin
- K:
-
Keratin
- P. acnes :
-
Propionibacterium acnes
- PPAR:
-
Peroxisome proliferator-activated receptor
- mTORC1:
-
Mammalian target of rapamycin complex 1
- SCD:
-
Stearoyl-CoA desaturase
- TLR:
-
Toll-like receptor
References
Alestas T, Ganceviciene R, Fimmel S, Müller-Decker K, Zouboulis CC. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med. 2006;84:75–87.
Anttila HS, Reitamo S, Saurat J-H. Interleukin 1 immunoreactivity in sebaceous glands. Br J Dermatol. 1992;127:585–8.
Boelsma E, Tanojo H, Boddé HE, Ponec M. Assessment of the potential irritancy of oleic acid on human skin: Evaluation in vitro and in vivo. Toxicol In Vitro. 1996;10:729–42.
Böhm M, Schiller M, Ständer S, et al. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol. 2002;118:533–9.
Chen W, Yang C-C, Sheu E-M, Seltmann H, Zouboulis CC. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol. 2003;121:441–7.
Chen W, Tsai S-J, Sheu H-M, Tsai J-C, Zouboulis CC. Testosterone synthesized in cultured human SZ95 sebocytes mainly derives from dehydroepiandrosterone. Exp Dermatol. 2010;19:470–2.
Chen CH, Wang Y, Nakatsuji T, et al. An innate bactericidal oleic acid effective against skin infection of methicillin-resistant staphylococcus aureus: a thera-py concordant with evolutionary medicine. J Microbiol Biotechnol. 2011;21:391–9.
Chiba K, Yoshizawa K, Makino I, Kawakami K, Onoue M. Comedogenicity of squalene monohydroperoxide in the skin after topical application. J Toxicol Sci. 2000;25:77–83.
Choi EH, Ahn SK, Lee SH. The changes of stratum corneum interstices and calcium distribution of follicular epithelium of experimentally induced comedones (EIC) by oleic acid. Exp Dermatol. 1997;6:29–35.
Chronnell CM, Ghali LR, Ali RS, et al. Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol. 2001;117:1120–5.
Downing DT, Strauss JS, Pochi PE. Changes in skin surface lipid composition induced by severe caloric restriction in man. Am J Clin Nutr. 1972;25:365–7.
Downing DT, Stewart ME, Wertz PW, Strauss JS. Essential fatty acids and acne. J Am Acad Dermatol. 1986;14:221–5.
Drake DR, Brogden KA, Dawson DV, Wertz PW. Antimicrobial lipids at the skin surface. J Lipid Res. 2008;49:4–11.
Ferré P. The biology of peroxisome proliferators-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes. 2004;53:43–50.
Fritsch M, Orfanos CE, Zouboulis CC. Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol. 2001;116:793–800.
Ganceviciene R, Graziene V, Fimmel S, Zouboulis CC. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol. 2009;160:345–52.
Georgel P, Crozat K, Lauth X et al. A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with Gram-positive bacteria. Infect Immun. 2005;73:4512–21.
Guy R, Green MR, Kealey T. Modeling acne in vitro. J Invest Dermatol. 1996;106:176–82.
Hughes BR, Morris C, Cunliffe WJ, Leigh IM. Keratin expression in pilosebaceous epithelia in truncal skin of acne patients. Br J Dermatol. 1996;134:247–56 .
Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ. Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol. 1992;98:895–901.
Ingham E, Walters CE, Eady EA, Cove JH, Kearney JN, Cunliffe WJ. Inflammation in acne vulgaris: failure of skin micro-organisms to modulate keratinocyte inter-leukin 1 alpha production in vitro. Dermatology. 1998;196:86–8.
Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121:20–7.
Kang S, Cho S, Chung JH, Hammerberg C, Fisher, GJ, Voorhees JJ. Inflammation and extracellular matrix degradation mediated by activated transcription fac-tors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol. 2005;166:1691–9.
Katsuta Y, Iida T, Inomata S, Denda M. Unsaturated fatty acids induce calcium influx into keratinocytes and cause abnormal differentiation of epidermis. J Invest Dermatol. 2005;124:1008–13.
Koreck A, Pivarcsi A, Dobozy A, Kémeny L. The role of innate immunity in the pathogenesis of acne. Dermatology. 2003;206:96–105.
Krause K, Schnitger A, Fimmel S, Glass E, Zouboulis CC. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res. 2007;39:166–70.
Kurokawa I, Mayer-da-Silva A, Gollnick H, Orfanos CE. Monoclonal antibody labeling for cytokeratins and filaggrin in the human pilosebaceous unit of normal, seborrhoeic and acne skin. J Invest Dermatol. 1988;91:566–71.
Letawe C, Boone M, Piérard GE. Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones. Clin Exp Dermatol. 1998;23:56–8.
Liakou AI, Theodorakis MJ, Melnik BC, Pappas A, Zouboulis CC. Nutritional clinical studies in dermatology. J Drugs Dermatol. 2013;12:1104–9.
Macdonald I. Changes in the fatty acid composition of sebum associated with high carbohydrate diets. Nature. 1964;203:1067–8.
Makrantonaki E, Zouboulis CC. Testosterone metabolism to 5α-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferators-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol. 2007;156:428–32.
Makrantonaki E, Ganceviciene R, Zouboulis CC. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinology. 2011;3:41–9.
Melnik BC, Schmitz G. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol. 2009;18:833–41.
Melnik BC, Zouboulis CC. Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne. Exp Dermatol. 2013;22:311–5.
Melnik B, Kinner T, Plewig G. Influence of oral isotretinoin treatment on the composition of comedonal lipids. Implications for comedogenesis in acne vulgaris. Arch Dermatol Res. 1988;280:97–102.
Nagy I, Pivarcsi A, Kis K, et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect. 2006;8:2195–205.
Nakatsuji T, Kao MC, Zhang L, Zouboulis CC, Gallo RL, Huang C-M. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating β-defensin-2 expression. J Invest Dermatol. 2010;130:985–94.
Namazi MR. Further insight into the pathomechanism of acne by considering the 5-alpha-reductase inhibitory effect of linoleic acid. Int J Dermatol. 2004;43:701.
Neufang G, Fürstenberger G, Heidt M, Marks F, Müller-Decker K. Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxy-genase-2 in skin. Proc Natl Acad Sci U S A. 2001;98:7629–34.
Nicolaides N, Wells GC. On the biogenesis of the free fatty acids in human skin surface fat. J Invest Dermatol. 1957;29:423–33.
Nicolaides N, Fu HC, Ansari MNA, Rice GR. The fatty acids of esters and sterol esters from vernix caseosa and from human surface lipid. Lipids. 1972;7:506–17.
Nikkari T. Comparative chemistry of sebum. J Invest Dermatol. 1974;62:257–67.
Oeff MK, Seltmann H, Hiroi N, et al. Differential regulation of toll-like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes. Dermatology. 2006;213:266.
Ottaviani M, Alestas T, Flori E, Mastrofrancesco A, Zouboulis CC, Picardo M. Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: a possible role in acne vulgaris. J Invest Dermatol. 2006;126:2430–7.
Ottaviani M, Camera E, Picardo M. Lipid mediators in acne. Mediators Inflamm. 2010;2010:pii:858176.
Pappas A. The relationship of diet and acne: a review. Dermatoendocrinol. 2009a;1:262–7.
Pappas A. Epidermal surface lipids. Dermatoendocrinology. 2009b;1:72–6.
Pappas A, Johnsen S, Liu JC, Eisinger M. Sebum analysis of individuals with and without acne. Dermatoendocrinology. 2009;1:157–61.
Patel SD, Noble WC. Changes in skin surface lipid composition during therapy for severe acne vulgaris and relation to colonisation with propionibacteria. Microb Ecol Health Dis. 1992;5:291–7.
Pochi PE, Downing DT, Strauss JS. Sebaceous gland response in man to prolonged total caloric deprivation. J Invest Dermatol. 1970;55:303–9.
Picardo M, Ottaviani M, Camera E, Mastrofrancesco A. Sebaceous gland lipids. Dermatoendocrinology. 2009;1:68–71.
Ramasastry P, Downing DT, Pochi PE, Strauss JS. Chemical composition of human skin surface lipids from birth to puberty. J Invest Dermatol. 1970;54:139–44.
Rasmussen JE. Diet and acne. Int J Dermatol. 1997;16:488–92.
Saint-Léger D. Fonction sébacée normale et pathologique. Des recherches au milieu du gué? Pathol Biol (Paris). 2003;51:275–8.
Samson M, Labrie F, Zouboulis CC, Luu-The V. Biosynthesis of dihydrotestosterone by a pathway that does not require testosterone as intermediate in the SZ95 sebaceous gland cell line. J Invest Dermatol. 2010;130:602–4.
Seltmann H, Rudawski IM, Holland KT, Orfanos CE, Zouboulis CC. Propionibacterium acnes does not influence the interleukin-1/interleukin-8 cascade in immortalized human sebocytes in vitro. J Invest Dermatol. 2000;114:816.
Seltmann H, Nikolakis G, Zouboulis CC. Novel pattern of sebaceous differentiation and lipogenesis induced by the ω-9 fatty acid palmitic acid. Exp Dermatol. 2013;22:e18.
Slominski A, Zbytek B, Nikolakis G, et al. Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol. 2013;137 107–123.
Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA. A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr. 2007;86:107–15.
Smith RN, Braue A, Varigos GA, Mann NJ. The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides. J Dermatol Sci. 2008;50:41–52.
Stewart ME. Sebaceous gland lipids. Semin Dermatol. 1992;11:100–5.
Stewart ME, Benoit AM, Downing DT, Strauss JS. Suppression of sebum secretion with 13-cis-retinoic acid: effect on individual skin surface lipids and implications for their anatomic origin. J Invest Dermatol. 1984;82:74–8.
Stewart ME, Grahek MO, Cambier LS, Wertz PW, Downing DT. Dilutional effect of increased sebaceous gland activity on the proportion of linoleic acid in sebaceous wax esters and in epidermal acylceramides. J Invest Dermatol. 1986;87:733–6.
Strauss JS, Stewart ME, Downing DT. The effect of 13-cis-retinoic acid on sebaceous glands. Arch Dermatol. 1987;123:1538a–41.
Song PI, Park YM, Abraham T, et al. Human keratinocytes express functional CD14 and toll-like receptor 4. J Invest Dermatol. 2002;119:424–32.
Thiboutot D, Jabara S, McAllister JM, et al. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol. 2003;120:905–14.
Tochio T, Tanaka H, Nakata S, Ikeno H. Accumulation of lipid peroxide in the content of comedones may be involved in the progression of comedogenesis and inflammatory changes in comedones. J Cosmet Dermatol. 2009;8:152–8.
Trivedi NR, Gilliland KL, Zhao W, Liu W, Thiboutot DM. Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J Invest Dermatol. 2006a;126:1071–9.
Trivedi NR, Cong Z, Nelson AM, et al. Peroxisome proliferator-activated receptors increase human sebum production. J Invest Dermatol. 2006b;126:2002–9.
Wang H, Brown J, Gu Z, et al. Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response. J Immunol. 2011;186:5217–26.
Wille JJ, Kydonieus A. Palmitoleic acid isomer (C16:1δ6) is the active antimicrobial fatty acid in human skin sebum. Skin Pharmacol Appl Skin Physiol. 2003;16:176–87.
Wróbel A, Seltmann H, Fimmel S, et al. Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol. 2003;120:175–81.
Zhang Q, Seltmann H, Zouboulis CC, Konger RL. Involvement of PPAR-gamma in oxidative stress-mediated prostaglandin E2 production in SZ95 human sebaceous gland cells. J Invest Dermatol. 2006;126:42–8.
Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology. 2001;203:77–9.
Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol. 2004a;22:360–6.
Zouboulis CC. The human skin as a hormone target and an endocrine gland. Hormones. 2004b;3:9–26.
Zouboulis CC. Zileuton, a new efficient and safe systemic anti-acne drug. Dermatoendocrinology. 2009;1:188–92.
Zouboulis CC, Korge B, Akamatsu H, et al. Effects of 13-cis-retinoic acid, all-trans-retinoic acid and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J Invest Dermatol. 1991;96:792–7.
Zouboulis CC, Seltmann H, Hiroi N, et al. Corticotropin releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A. 2002;99:7148–53.
Zouboulis CC, Fimmel S, Ortmann J, Turnbull JR, Boschnakow A. Sebaceous glands. In Hoath SB, Maibach HI, editors. Neonatal skin: structure and function. 2nd ed. New York: Marcel Dekker; 2003. pp. 59–88.
Zouboulis CC, Eady A, Philpott M, et al. What is the pathogenesis of acne? Exp Dermatol. 2005;14:143–52.
Zouboulis CC, Seltmann H, Alestas T. Zileuton prevents the activation of the leukotriene pathway and reduces sebaceous lipogenesis. Exp Dermatol. 2010;19:148–50.
Zouboulis CC, Angres S, Seltmann H. Regulation of stearoyl-CoA desaturase and fatty acid desaturase 2 expression by linoleic acid and arachidonic acid in human sebocytes leads to enhancement of proinflammatory activity but does not affect lipogenesis. Br J Dermatol. 2011;165:269–76.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zouboulis, C., Jourdan, E., Picardo, M. (2015). Acne and Lipid Pathways. In: Pappas, A. (eds) Lipids and Skin Health. Springer, Cham. https://doi.org/10.1007/978-3-319-09943-9_23
Download citation
DOI: https://doi.org/10.1007/978-3-319-09943-9_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09942-2
Online ISBN: 978-3-319-09943-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)